Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Theodore S Hong

Showing results (171-180 of 306) with videos related to

Pageof 31
Sort By:
American Journal of Clinical Oncology|October 15, 2016
Intraoperative Radiotherapy in the Era of Intensive Neoadjuvant Chemotherapy and Chemoradiotherapy for Pancreatic AdenocarcinomaFlorence K Keane, Jennifer Y Wo, Cristina R Ferrone, et al.
International Journal of Radiation Oncology, Biology, Physics|July 12, 2015
NRG Oncology Radiation Therapy Oncology Group 0822: A Phase 2 Study of Preoperative Chemoradiation Therapy Using Intensity Modulated Radiation Therapy in Combination With Capecitabine and Oxaliplatin for Patients With Locally Advanced Rectal CancerTheodore S Hong, Jennifer Moughan, Michael C Garofalo, et al.
International Journal of Radiation Oncology, Biology, Physics|January 2, 2009
Elective clinical target volumes for conformal therapy in anorectal cancer: a radiation therapy oncology group consensus panel contouring atlasRobert J Myerson, Michael C Garofalo, Issam El Naqa, et al.
The Lancet. Gastroenterology & Hepatology|February 24, 2025
Emerging evidence-based role for external-beam radiation therapy in hepatocellular carcinomaStephanie O Dudzinski, Neil B Newman, Jeff McIntyre, et al.
American Journal of Surgery|October 5, 2010
The effect of neoadjuvant chemoradiation therapy on the prognostic value of lymph nodes after rectal cancer surgeryCoen L Klos, Paul C Shellito, David W Rattner, et al.
Cancer|October 25, 2011
Long-term outcomes of neoadjuvant chemotherapy before chemoradiation for locally advanced pancreatic cancerNils D Arvold, David P Ryan, Andrzej Niemierko, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 2, 2016
A protein and mRNA expression-based classification of gastric cancerNamrata Setia, Agoston T Agoston, Hye S Han, et al.
Annals of Surgical Oncology|November 24, 2019
Intraoperative Radiation Therapy (IORT) for Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma (BR/LA PDAC) in the Era of Modern Neoadjuvant Treatment: Short-Term and Long-Term OutcomesJon M Harrison, Jennifer Y Wo, Cristina R Ferrone, et al.
Gastrointestinal Cancer Research : GCR|February 28, 2012
Intraductal papillary mucinous adenocarcinoma of the pancreas: clinical outcomes, prognostic factors, and the role of adjuvant therapyBrian M Alexander, Carlos Fernandez-Del Castillo, David P Ryan, et al.
The Oncologist|December 19, 2018
Neoadjuvant FOLFIRINOX for Patients with Borderline Resectable or Locally Advanced Pancreatic Cancer: Results of a Decision AnalysisJin G Choi, Ryan D Nipp, Angela Tramontano, et al.
Pageof 31

Showing results (171-180 of 306) with videos related to

Sort By:
Pageof 31
American Journal of Clinical Oncology|October 15, 2016
Intraoperative Radiotherapy in the Era of Intensive Neoadjuvant Chemotherapy and Chemoradiotherapy for Pancreatic AdenocarcinomaFlorence K Keane, Jennifer Y Wo, Cristina R Ferrone, et al.
International Journal of Radiation Oncology, Biology, Physics|July 12, 2015
NRG Oncology Radiation Therapy Oncology Group 0822: A Phase 2 Study of Preoperative Chemoradiation Therapy Using Intensity Modulated Radiation Therapy in Combination With Capecitabine and Oxaliplatin for Patients With Locally Advanced Rectal CancerTheodore S Hong, Jennifer Moughan, Michael C Garofalo, et al.
International Journal of Radiation Oncology, Biology, Physics|January 2, 2009
Elective clinical target volumes for conformal therapy in anorectal cancer: a radiation therapy oncology group consensus panel contouring atlasRobert J Myerson, Michael C Garofalo, Issam El Naqa, et al.
The Lancet. Gastroenterology & Hepatology|February 24, 2025
Emerging evidence-based role for external-beam radiation therapy in hepatocellular carcinomaStephanie O Dudzinski, Neil B Newman, Jeff McIntyre, et al.
American Journal of Surgery|October 5, 2010
The effect of neoadjuvant chemoradiation therapy on the prognostic value of lymph nodes after rectal cancer surgeryCoen L Klos, Paul C Shellito, David W Rattner, et al.
Cancer|October 25, 2011
Long-term outcomes of neoadjuvant chemotherapy before chemoradiation for locally advanced pancreatic cancerNils D Arvold, David P Ryan, Andrzej Niemierko, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 2, 2016
A protein and mRNA expression-based classification of gastric cancerNamrata Setia, Agoston T Agoston, Hye S Han, et al.
Annals of Surgical Oncology|November 24, 2019
Intraoperative Radiation Therapy (IORT) for Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma (BR/LA PDAC) in the Era of Modern Neoadjuvant Treatment: Short-Term and Long-Term OutcomesJon M Harrison, Jennifer Y Wo, Cristina R Ferrone, et al.
Gastrointestinal Cancer Research : GCR|February 28, 2012
Intraductal papillary mucinous adenocarcinoma of the pancreas: clinical outcomes, prognostic factors, and the role of adjuvant therapyBrian M Alexander, Carlos Fernandez-Del Castillo, David P Ryan, et al.
The Oncologist|December 19, 2018
Neoadjuvant FOLFIRINOX for Patients with Borderline Resectable or Locally Advanced Pancreatic Cancer: Results of a Decision AnalysisJin G Choi, Ryan D Nipp, Angela Tramontano, et al.
Pageof 31